This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Aventis Pharmaceuticals Inc.. Active years: 2002-2004.
Location History:
- Kansas City, MO (US) (2002)
- Leawood, KS (US) (2004)
Company Filing History:
Years Active: 2002-2004
Title: The Innovations of Paul Wayne Brown
Introduction
Paul Wayne Brown is a notable inventor based in Leawood, Kansas. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. With a total of 3 patents to his name, Brown's work has the potential to impact various medical treatments.
Latest Patents
One of his latest patents is for sulfuric acid mono-[3-({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-hydroxy-methyl)-2-methoxy-phenyl]ester. This invention is directed towards a metabolite of the 5HT antagonist (+)-α-(2,3-dimethoxyphenyl)-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol, along with processes for its preparation and use in treating various disease states. Another patent focuses on antihistaminic piperidine derivatives and intermediates for their preparation.
Career Highlights
Paul Wayne Brown is currently employed at Aventis Pharmaceuticals Inc., where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
Brown has collaborated with notable colleagues such as Ronald Charles Bernotas and Gary Emmons, contributing to a dynamic and innovative work environment.
Conclusion
Paul Wayne Brown's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.